DESCRIPTION

PM1000N incorporates the latest Nellcor™ digital signal processing and cardiac-based technology for accurate, reliable readings. Because Nellcor™ pulse oximetry is closely tied to patient physiology, it drives consistent performance during various challenging conditions, such as patient movement, noise, and low perfusion which can impede the assessment of patient respiratory status. The patient monitoring system is also cleared as a motion-­tolerant bedside pulse oximeter that is compliant with ISO 80601--­2--­61. The System is designed to provide continuous SpO2, pulse rate and respiration rate monitoring with efficiency that brings this device to the top of the line among other pulse oximeters available on the market. It comprises an innovative technology that ensures a quicker response to the changes in patients’ oxygenation and pulse rate. In a combination with a Saturation Pattern Detection (SPD) alert, this technology allows for the early detection of respiratory complications and, therefore, a sooner intervention. Moreover, this Bedside Monitor is the 1st and only device on the current market that has obtained the FDA clearance for a motion-tolerant pulse oximetry and compliance with ISO 80601-2-61. The latest Nellcor™ signal processing technology is proven to provide superior measurement capabilities even under difficult monitoring conditions. It ensures accurate assessment of patient SpO2 and pulse rate status at all times and under various degrees signal interference including low perfusion, patient motion or noise, avoiding dropouts or delays. The device features 1% to 100% SpO2 and 20 to 250 bpm measurement range on both neonate and adult patients.